Achieve Life Science's Reverse Merger Round

Achieve Life Science raised a round of funding on January 05, 2017. Investors include OncoGenex Pharmaceuticals.

Achieve Life Science is a specialty pharmaceutical company focused on clinical and commercial development of cytisine, a selective nicotine receptor partial agonist currently in late-stage development…

Articles about Achieve Life Science's Reverse Merger Round: